The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2022

Filed:

Jan. 31, 2019
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Xiaobin Xu, White Plains, NY (US);

Yu Huang, Ossining, NY (US);

Assignee:

Regeneran Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/50 (2006.01); G16B 5/20 (2019.01); G06F 17/11 (2006.01); G01N 33/68 (2006.01); C07K 16/00 (2006.01); G16B 20/20 (2019.01);
U.S. Cl.
CPC ...
G16B 5/20 (2019.02); G01N 33/6842 (2013.01); G01N 33/6854 (2013.01); G06F 17/11 (2013.01); C07K 16/00 (2013.01); C07K 2317/00 (2013.01); G01N 2440/00 (2013.01); G16B 20/20 (2019.02);
Abstract

Methods of predicting an in vivo serum concentration of an antibody with a post-translational modification of interest after administration of the antibody are provided, as are methods for predicting a subject's exposure to post-translational variants of the antibody. The methods include predicting a percentage of the antibody with the post-translational modification of interest using an in vivo rate constant determined for the post-translational modification, and multiplying the predicted percentage of the antibody with the post-translational modification of interest by the in vivo concentration of the antibody to determine the concentration of the antibody with the post-translational modification of interest.


Find Patent Forward Citations

Loading…